Lumicell Diagnostics

About Lumicell Diagnostics

Lumicell Diagnostics is a medical technology company that has developed an intraoperative imaging system to assist surgeons in the removal of cancerous tissue. The company's core product is the Lumicell Direct Visualization System (DVS), which utilizes a proprietary optical imaging agent to illuminate cancer cells in real-time during surgery. This allows surgeons to more accurately identify and resect malignant tissue that may not be visible to the naked eye, with the goal of reducing the incidence of positive margins and the need for repeat surgeries.

The company's business model is centered on the sale of the DVS hardware and the accompanying single-use imaging agents. Lumicell is targeting the oncology surgery market, with an initial focus on breast cancer, and plans to expand to other cancer types. The company is in the process of commercialization, having raised significant venture capital funding to support its growth and market entry. Lumicell operates in the medical device and diagnostic imaging sector, a market characterized by stringent regulatory requirements and a high degree of specialization.